Cargando…
Effect of Pentoxifylline on Microalbuminuria in Diabetic Patients: A Randomized Controlled Trial
Background. Pentoxifylline is a nonspecific phosphodiesterase inhibitor with anti-inflammatory properties. Human studies have proved its antiproteinuric effect in patients with glomerular diseases, but this study was designed to assess the effects of add-on pentoxifylline to available treatment on r...
Autores principales: | Shahidi, Shahrzad, Hoseinbalam, Marziyeh, Iraj, Bijan, Akbari, Mojtaba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385644/ https://www.ncbi.nlm.nih.gov/pubmed/25874129 http://dx.doi.org/10.1155/2015/259592 |
Ejemplares similares
-
Pentoxifylline treatment in patients with cancer cachexia: A double-blind, randomized, placebo-controlled clinical trial
por: Mehrzad, Valiollah, et al.
Publicado: (2016) -
The Effects of Berberis integerrima Fruit Extract on Glycemic Control Parameters in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Clinical Trial
por: Soltani, Rasool, et al.
Publicado: (2021) -
Screening for Microalbuminuria in HIV-Positive Children in Enugu
por: Bertilla Uzoma, Ezeonwu, et al.
Publicado: (2012) -
Association between Urinary N-Acetyl-Beta-D-Glucosaminidase and Microalbuminuria in Diabetic Black Africans
por: Udomah, Francis Patrick, et al.
Publicado: (2012) -
Role of Pentoxifylline and Sparfloxacin in Prophylaxis of Spontaneous Bacterial Peritonitis in Cirrhotic Patients
por: Mostafa, Tarek Mohammed, et al.
Publicado: (2014)